Nasdaq, Inc. (BKK:NDAQ06)

Ligand Pharmaceuticals Revenue

Nasdaq had revenue of $2.09B USD in the quarter ending June 30, 2025, with 16.63% growth. This brings the company's revenue in the last twelve months to $8.11B, up 23.51% year-over-year. In the year 2024, Nasdaq had annual revenue of $7.40B with 22.03% growth.

• Revenue (ttm): $8.11B
• Revenue Growth: +23.51%
• P/S Ratio: 6.83
• Revenue / Employee: $885.29K
• Employees: 9,162
• Market Cap: 1,800.20B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.40B	1.34B	22.03%
Dec 31, 2023	6.06B	-162.00M	-2.60%
Dec 31, 2022	6.23B	340.00M	5.78%
Dec 31, 2021	5.89B	261.00M	4.64%
Dec 31, 2020	5.63B	1.37B	32.10%